A Study of the Safety of Atezolizumab in Participants With Locally Advanced or Metastatic Non Small Cell Lung Cancer in Argentina
CompletedOBSERVATIONAL
Enrollment
44
Participants
Timeline
Start Date
December 27, 2017
Primary Completion Date
March 2, 2019
Study Completion Date
March 2, 2019
Conditions
Carcinoma, Non-small-cell Lung
Trial Locations (1)
B1610BAL
Productos Roche S.A. Quimica e Industrial, División Farmacéutica, Buenos Aires
All Listed Sponsors
lead
Hoffmann-La Roche
INDUSTRY
NCT03321695 - A Study of the Safety of Atezolizumab in Participants With Locally Advanced or Metastatic Non Small Cell Lung Cancer in Argentina | Biotech Hunter | Biotech Hunter